Is pasireotide FDA-approved?

Yes, as specific products: Signifor and Signifor LAR (pasireotide) injections are FDA-approved prescription medicines for the uses in their labels.

Checked 1 Nov 2026. The sources are below.

Pasireotide

Also: Signifor, Signifor LAR, SOM230

Status label in the Peptimes Library
FDA Approved
Routes in Peptimes
SubcutaneousIntramuscular
Updated
1 Nov 2026

US regulatory status

FDA approval belongs to each product below, for its route and the uses in its label. Label uses are shortened unless quoted.

  • Signifor (pasireotide) injection

    Subcutaneous

    Adults with Cushing's disease for whom pituitary surgery is not an option or has not been curative.

    Source: DailyMed label, checked 1 Nov 2026

  • Signifor LAR (pasireotide) for injectable suspension

    Intramuscular

    Acromegaly after an inadequate response to surgery or when surgery is not an option, and Cushing's disease when pituitary surgery is not an option or has not been curative.

    Source: DailyMed label, checked 1 Nov 2026

  • Investigational

    No, for the products and uses above.

    Source: Drugs@FDA, checked 1 Nov 2026

How to track it in Peptimes

Add pasireotide in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “FDA Approved”; the entries above give the products it applies to.

  • Routes: subcutaneous or intramuscular. Choose the one that matches each dose.
  • Logging: the amount you took, the route and how you feel.
  • Injection sites: subcutaneous and intramuscular doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next.
  • Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.

Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell pasireotide or any other compound.

More sources

  • FDA, Drugs@FDA: NDA 200677 (Signifor) and NDA 203255 (Signifor LAR), checked 1 Nov 2026: product, route and marketing status.
  • FDA, Global Substance Registration System, Pasireotide, checked 1 Nov 2026: its structure as a ring of six amino acids and the code SOM230.

Brand names on this page are trademarks of their owners. Peptimes isn't affiliated with or endorsed by them.

Coming soon to the App Store

Coming soon to Google Play

See planned pricing